Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Nollet

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Antibodies (Basel, Switzerland)|September 25, 2019
Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of TumorsJimmy Stalin, Marie Nollet, Françoise Dignat-George, et al.
Theranostics|November 16, 2018
Early prediction of revascularisation by angiomotin-targeting positron emission tomographyAnais Moyon, Philippe Garrigue, Laure Balasse, et al.
Autophagy|January 30, 2026
<i>Atg5</i>/Autophagy inactivation in mouse bone microenvironment promotes tumor developmentMarie-Charlotte Trojani, Marie Nollet, Olivier Camuzard, et al.
Scientific Reports|June 22, 2018
Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapyAmel Essaadi, Marie Nollet, Anaïs Moyon, et al.
International Journal of Cancer|February 6, 2020
Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumorsJimmy Stalin, Wael Traboulsi, Lucie Vivancos-Stalin, et al.
Autophagy Reports|May 21, 2025
Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factorsOlivier Camuzard, Marie Nollet, Sabine Santucci-Darmanin, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Antibodies (Basel, Switzerland)|September 25, 2019
Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of TumorsJimmy Stalin, Marie Nollet, Françoise Dignat-George, et al.
Theranostics|November 16, 2018
Early prediction of revascularisation by angiomotin-targeting positron emission tomographyAnais Moyon, Philippe Garrigue, Laure Balasse, et al.
Autophagy|January 30, 2026
<i>Atg5</i>/Autophagy inactivation in mouse bone microenvironment promotes tumor developmentMarie-Charlotte Trojani, Marie Nollet, Olivier Camuzard, et al.
Scientific Reports|June 22, 2018
Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapyAmel Essaadi, Marie Nollet, Anaïs Moyon, et al.
International Journal of Cancer|February 6, 2020
Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumorsJimmy Stalin, Wael Traboulsi, Lucie Vivancos-Stalin, et al.
Autophagy Reports|May 21, 2025
Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factorsOlivier Camuzard, Marie Nollet, Sabine Santucci-Darmanin, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Pageof 2